医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Agilent Technologies Presents Thought Leader Award to Renowned Medicinal Scientist in China

2016年04月30日 AM12:00
このエントリーをはてなブックマークに追加


 

SANTA CLARA, Calif.

Agilent Technologies Inc. (NYSE:A) today announced that Dr. Shilin Chen has received an Agilent Thought Leader Award in support of his groundbreaking herbal genomics research using multi-omics techniques.

Dr. Chen directs the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences in Beijing. The institute strives to identify the active ingredients in traditional Chinese medicines and make new drugs.

The award will fund the use of integrated biology—including various multi-omic solutions from Agilent—to generate important biological data sets related to the biosynthesis of bioactive compounds from herbs, including artemisinin and glycyrrhizin, for example.

Through his research, Dr. Chen hopes to deepen understanding of the mechanism by which herbal medicines disrupt diseases and identify relevant biomarkers, which could then point the way to new drug discovery.

“We are delighted to receive an Agilent Thought Leader Award. It will allow us to incorporate integrated experimental and bioinformatics approaches to traditional Chinese medicine,” said Dr. Chen. “Our group is focusing on dissecting and understanding the biosynthesis and regulatory mechanisms responsible for specific metabolic processes generated by natural herbs. We have initiated the herbal genomic project, and Agilent’s innovative technologies and unique solutions can provide new tools and approaches to help us combine metabolomics and genomics in the study of traditional Chinese medicine. We are looking forward to working collaboratively with Agilent scientists to accelerate the discovery and characterization of new medicines.”

“We are pleased to support Dr. Chen’s efforts in the systems-level analysis of herbal metabolic processes using integrated omics approaches,” said Dr. Teng Chai Hock, vice president and general manager of Agilent’s Life Sciences and Applied Markets Group in Greater China. “Dr. Chen’s research is a prime example of continued innovation in traditional Chinese medicine through the application of advanced analytical methods.”

The Agilent Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and applied chemical markets. Information about previous award recipients is available at Agilent’s Thought Leader website.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenue of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160429005119/en/

CONTACT

Agilent Technologies Inc.
Victoria Wadsworth-Hansen, +1 408-553-2005
victoria.wadsworth-hansen@agilent.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement
  • 新研究调查诊断性多通道睡眠检查之前采用Masimo SET®脉搏氧饱和度仪居家监测筛查唐氏综合征患儿罹患阻塞性睡眠呼吸暂停的风险
  • ダウン症候群の小児を対象とする睡眠時障害診断のマルチチャンネル研究に先立つ閉塞性睡眠時無呼吸症リスクのスクリーニングとしてMasimo SET®パルスオキシメトリーを使用するホームモニタリングの有用性を検討する新研究